A novel signature to predict the neoadjuvant chemotherapy response of bladder carcinoma: Results from a territory multicenter real-world study

Background: Although neoadjuvant chemotherapy (NAC) has become the standard treatment option for muscle invasive bladder carcinoma (MIBC), its application is still limited because of the lack of biomarkers for NAC prediction. Methods: We conducted a territory multicenter real-world study to summariz...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huihuang, Hu, Jiao, Zu, Xiongbing, Chen, Minfeng, Chen, Jinbo, Zou, Yihua, Deng, Ruoping, Qin, Gang, Li, Wenze, Tang, Jiansheng, Deng, Dingshan, Liu, Jinhui, Cheng, Chunliang, Cui, Yu, Ou, Zhenyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667090/
https://www.ncbi.nlm.nih.gov/pubmed/36406127
http://dx.doi.org/10.3389/fgene.2022.1047481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667090/
https://www.ncbi.nlm.nih.gov/pubmed/36406127
http://dx.doi.org/10.3389/fgene.2022.1047481

Ejemplares similares